Optimized Response Assessment of Gastrointestinal Stromal Tumors Using Dual-Energy CT: A Prospective Multicenter-Multinational Trail in Patients Undergoing Targeted Therapy with a tyrosine-kinase-inhibitor

Not Applicable

• Conditions: C16; C17; C18; Malignant neoplasm of stomach; Malignant neoplasm of small intestine; Malignant neoplasm of colon

• Registration Number: DRKS00008173
• Lead Sponsor: niversitätsklinikum Mannheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-07-29
• Study Completion: 2021-12-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 138

Inclusion Criteria

All patients histological proven Gastrointestinal Stromal Tumors and undergoing systemic target treatment will be included.

Exclusion Criteria

Patients younger than 18 years or with contraindication to a contrast-enhanced CT scan.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression-free survival within 2 years.

Secondary Outcome Measures

Name	Time	Method
Overall survival within 2 years.